Tag: https://www.bio.org/events/bio-international-convention
Senator Markwayne Mullin criticizes PBMs at the Senate Committee on Health, Education, Labor and Pensions (HELP) Hearing on “The Need to Make Insulin Affordable for All Americans,” and Rep. Kevin Hern discusses orphan drugs and innovation at the House Ways and Means Committee Health Subcommittee Hearing on “Examining Policies that Inhibit Innovation and Patient Access”. […]
Senator Markwayne Mullin criticizes PBMs at the Senate Committee on Health, Education, Labor and Pensions (HELP) Hearing on “The Need to Make Insulin Affordable for All Americans.” Wednesday, May 10, 2023 source
Rep. Kevin Hern discusses orphan drugs and innovation at the House Ways and Means Committee Health Subcommittee Hearing on “Examining Policies that Inhibit Innovation and Patient Access”. Wednesday, May 10, 2023 source
BIO’s Chief Advocacy Officer Nick Shipley talks about the significance of the Senate HELP Committee’s bipartisan vote to advance a bill to reform PBMs. (May 11, 2023) source
Lawmakers hear testimony on how PBMs leave patients behind to fend for themselves at a hearing of the House Committee on Oversight and Accountability: “The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part I: Self-Interest or Health Care?” BIO’s Nick Shipley explains why legislation on PBM reform is important. Full story on Bio.News: […]
The Committee on Energy and Commerce Oversight and Investigations Subcommittee held a hearing on “Antimicrobial Resistance: Examining an Emerging Public Health Threat” on April 28, 2023 source